CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma

Better and sensitive biomarkers are needed to help understand the mechanism of disease onset, progression, prognosis and monitoring of the therapeutic response. Aim of this study was to identify the candidate circulating markers of chronic-phase chronic myeloid leukemia (CP-CML) manifestations, havi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Iram, Sadaf, Saima, Musharraf, Syed Ghulam, Hashmi, Naghma, Akhtar, Muhammad Waheed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259771/
https://www.ncbi.nlm.nih.gov/pubmed/28117336
http://dx.doi.org/10.1038/srep40943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259771/
https://www.ncbi.nlm.nih.gov/pubmed/28117336
http://dx.doi.org/10.1038/srep40943

Ejemplares similares